Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Lung clearance index-triggered intervention in children with cystic fibrosis - A randomised pilot study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Pseudomonas aeruginosa antibody response in cystic fibrosis decreases rapidly following lung transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The impact of chest computed tomography and chest radiography on clinical management of cystic fibrosis lung disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. First case of cystic fibrosis in Greenland - diagnosed by neonatal screening

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Omics-based tracking of Pseudomonas aeruginosa persistence in "eradicated" cystic fibrosis patients.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Autologous fibrin sealant co-delivered with antibiotics is a robust method for topical antibiotic treatment after sinus surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

HYPOTHESIS: Using increase in the lung clearance index (LCI) as a trigger for bronchoalveolar lavage (BAL) and associated antimicrobial treatment might benefit clinical outcomes in children with cystic fibrosis (CF).

METHODS: A 2-year, longitudinal, interventional, randomized, controlled pilot study with quarterly visits in 5-18 years old children with CF. LCI and z-scores for the forced expired volume in 1 s (zFEV1) and body mass index (zBMI) were obtained at every visit, CF Questionnaire-revised (CFQ-R) yearly and BAL and chest computed tomography at first and last visit. Children in the intervention group had BAL performed if LCI increased >1 unit from a fixed baseline value established at first visit. If the presence of a pathogen was documented in the BAL fluid, treatment was initiated/altered accordingly.

RESULTS: Twenty-nine children with CF were randomized to the control (n = 14) and intervention group (n = 15). The median (interquartile range) number of BAL procedures per child was 2.5 (2.0; 3.0) and 6.0 (4.0; 7.0) in the control and intervention group, respectively. There was no significant difference between groups in slope for the primary outcome LCI; difference was 0.21 (95% confidence interval: -0.45; 0.88) units/year. Likewise, there was no significant difference between groups in slope for the secondary outcomes zFEV1, zBMI, CFQ-R respiratory symptom score and the proportion of total disease and trapped air on chest computed tomography.

CONCLUSIONS: LCI-triggered BAL and associated antimicrobial treatment did not benefit clinical outcomes in a small cohort of closely monitored school-age children with CF.

Original languageEnglish
JournalJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Volume19
Issue number6
Pages (from-to)934-941
Number of pages8
ISSN1569-1993
DOIs
Publication statusPublished - Nov 2020

ID: 62063937